458 related articles for article (PubMed ID: 22493083)
1. Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida ΔfopC vaccine strain.
Sanapala S; Yu JJ; Murthy AK; Li W; Guentzel MN; Chambers JP; Klose KE; Arulanandam BP
Infect Immun; 2012 Jun; 80(6):2177-85. PubMed ID: 22493083
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge.
Cong Y; Yu JJ; Guentzel MN; Berton MT; Seshu J; Klose KE; Arulanandam BP
Vaccine; 2009 Sep; 27(41):5554-61. PubMed ID: 19651173
[TBL] [Abstract][Full Text] [Related]
3. Evasion of IFN-γ signaling by Francisella novicida is dependent upon Francisella outer membrane protein C.
Nallaparaju KC; Yu JJ; Rodriguez SA; Zogaj X; Manam S; Guentzel MN; Seshu J; Murthy AK; Chambers JP; Klose KE; Arulanandam BP
PLoS One; 2011 Mar; 6(3):e18201. PubMed ID: 21483828
[TBL] [Abstract][Full Text] [Related]
4. CD4+ T cells are required during priming but not the effector phase of antibody-mediated IFN-gamma-dependent protective immunity against pulmonary Francisella novicida infection.
Powell HJ; Cong Y; Yu JJ; Guentzel MN; Berton MT; Klose KE; Murthy AK; Arulanandam BP
Immunol Cell Biol; 2008; 86(6):515-22. PubMed ID: 18427567
[TBL] [Abstract][Full Text] [Related]
5. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent
Jia Q; Horwitz MA
Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510
[No Abstract] [Full Text] [Related]
6. Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).
De Pascalis R; Chou AY; Ryden P; Kennett NJ; Sjöstedt A; Elkins KL
mBio; 2014 Apr; 5(2):e00936. PubMed ID: 24713322
[TBL] [Abstract][Full Text] [Related]
7. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.
Bakshi CS; Malik M; Mahawar M; Kirimanjeswara GS; Hazlett KR; Palmer LE; Furie MB; Singh R; Melendez JA; Sellati TJ; Metzger DW
Vaccine; 2008 Sep; 26(41):5276-88. PubMed ID: 18692537
[TBL] [Abstract][Full Text] [Related]
8. An
Golovliov I; Lindgren H; Eneslätt K; Conlan W; Mosnier A; Henry T; Sjöstedt A
Front Cell Infect Microbiol; 2016; 6():152. PubMed ID: 27933275
[No Abstract] [Full Text] [Related]
9. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.
Skyberg JA; Rollins MF; Samuel JW; Sutherland MD; Belisle JT; Pascual DW
Infect Immun; 2013 Sep; 81(9):3099-105. PubMed ID: 23774604
[TBL] [Abstract][Full Text] [Related]
10. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
[TBL] [Abstract][Full Text] [Related]
11. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
Baron SD; Singh R; Metzger DW
Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
[TBL] [Abstract][Full Text] [Related]
12. Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia.
Pammit MA; Raulie EK; Lauriano CM; Klose KE; Arulanandam BP
Infect Immun; 2006 Apr; 74(4):2063-71. PubMed ID: 16552035
[TBL] [Abstract][Full Text] [Related]
13. Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis.
Kieffer TL; Cowley S; Nano FE; Elkins KL
Microbes Infect; 2003 Apr; 5(5):397-403. PubMed ID: 12737995
[TBL] [Abstract][Full Text] [Related]
14. A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.
Jia Q; Bowen R; Sahakian J; Dillon BJ; Horwitz MA
Infect Immun; 2013 May; 81(5):1550-61. PubMed ID: 23439306
[TBL] [Abstract][Full Text] [Related]
15. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC
Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631
[TBL] [Abstract][Full Text] [Related]
16. Live attenuated Francisella novicida vaccine protects against Francisella tularensis pulmonary challenge in rats and non-human primates.
Chu P; Cunningham AL; Yu JJ; Nguyen JQ; Barker JR; Lyons CR; Wilder J; Valderas M; Sherwood RL; Arulanandam BP; Klose KE
PLoS Pathog; 2014 Oct; 10(10):e1004439. PubMed ID: 25340543
[TBL] [Abstract][Full Text] [Related]
17. Francisella tularensis T-cell antigen identification using humanized HLA-DR4 transgenic mice.
Yu JJ; Goluguri T; Guentzel MN; Chambers JP; Murthy AK; Klose KE; Forsthuber TG; Arulanandam BP
Clin Vaccine Immunol; 2010 Feb; 17(2):215-22. PubMed ID: 20016043
[TBL] [Abstract][Full Text] [Related]
18. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
[TBL] [Abstract][Full Text] [Related]
19. Inhalation of Francisella novicida Delta mglA causes replicative infection that elicits innate and adaptive responses but is not protective against invasive pneumonic tularemia.
West TE; Pelletier MR; Majure MC; Lembo A; Hajjar AM; Skerrett SJ
Microbes Infect; 2008 Jun; 10(7):773-80. PubMed ID: 18539500
[TBL] [Abstract][Full Text] [Related]
20. Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis.
Shen H; Chen W; Conlan JW
Microb Pathog; 2004 Aug; 37(2):107-10. PubMed ID: 15312850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
